After being diagnosed with acute myeloid leukemia (AML) at age 15, Hernan Barangan felt isolated and scared. Later, it led him to a new career path in filmmaking where he’s helping other young adults with cancer.
Journalist Loriana Hernandez-Aldama wasn’t expecting to hear she had cancer again -- and it was a different type than her first diagnosis. Here’s how she learned to cope with her secondary cancer diagnosis and prepare for treatment.
In these “Your Stories” podcasts from Conquer Cancer, the ASCO Foundation, individuals share their experiences with clinical trials.
Cancer.Net Associate Editors explain research presented at the 2019 ASCO Annual Meeting, including new research in colon cancer, gastric cancer, pancreatic cancer, and leukemia.
Improving Outcomes in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Research from the 2018 ASH Annual Meeting
In this podcast, Cancer.Net Associate Editor Dr. Guillermo Garcia-Manero describes MDS and AML research advances presented at the American Society of Hematology Annual Meeting.
People diagnosed with cancer often say they were stunned when they heard the news and unable to process what they heard afterward, as if a fog had obscured everything. After this initial shock, it is important to learn about what comes next. Leukemia survivor Doug Smith shares his experiences with coping with this fog.
A bone marrow/stem cell transplant is an effective treatment option for several cancers, even when the patient is older. Read how you and your doctor can determine if the treatment is right for you.
After being diagnosed with cancer, journalist Loriana Hernandez-Aldama learned that living a healthy lifestyle before treatment begins can help you cope with and manage the challenges to come. This practice of preparing yourself for cancer treatment is sometimes called prehabilitation.
Read key research highlights that will be presented at the 2018 ASCO Annual Meeting, including monitoring symptoms with technology, screening and genomic testing for lung cancer, and new treatment regimens for breast cancer and T-cell leukemia and lymphoma.
The 2018 Clinical Cancer Advances report of the American Society of Clinical Oncology has crowned an adoptive cell immunotherapy as its Advance of the Year. What is this innovative cancer treatment? What are the risks and benefits?